About: Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience
Creator	Adrish, Muhammad Alla, Yamini Attwood, Kristopher Chinta, Siddharth Hanif, Ahmad Hanif, Sana Jain, Kevin Ji, Wenyan Khan, Sumera Mantri, Nikhitha Saleh, Muhamed Shrestha, Nikee
Source	Medline; PMC
abstract	Infection with SARS-CoV-2 (COVID-19) can cause prothrombotic complications. We aim to study the frequency of thrombotic complications and impact of anticoagulation on outcomes in hospitalized patients. We conducted a retrospective chart review of 921 consecutive patients admitted to our hospital with COVID-19. Patients were divided into four groups depending on whether they were on anticoagulation prior to admission, started anticoagulation during the admission, received prophylactic anticoagulation, or did not receive any anticoagulation. At the time of analysis, 325 patients (35.3%) had died, while 544 patients (59%) had been discharged resulting in inpatient mortality of 37.3%. Male sex, age > 65 years, and high D-dimer at admission were associated with higher mortality. Sixteen patients (1.7%) had venous thromboembolism confirmed with imaging, 11 patients had a stroke, and 2 patients developed limb ischemia. Treatment with therapeutic anticoagulation was associated with improved inpatient mortality compared with prophylactic anticoagulation alone (63% vs 86.2%, p < 0.0001) in patients requiring mechanical ventilation. Other outcomes such as rates of liberation from mechanical ventilation and duration of mechanical ventilation were not significantly impacted by the type of anticoagulation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00277-020-04216-x) contains supplementary material, which is available to authorized users.
has issue date	2020-08-17(xsd:dateTime)
bibo:doi	10.1007/s00277-020-04216-x
bibo:pmid	32808105
has license	no-cc
sha1sum (hex)	011f0f03c6f952339a571428f824810fa8809564
schema:url	https://doi.org/10.1007/s00277-020-04216-x
resource representing a document's title	Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience
has PubMed Central identifier	PMC7430929
has PubMed identifier	32808105
schema:publication	Ann Hematol
resource representing a document's body	covid:011f0f03c6f952339a571428f824810fa8809564#body_text
is schema:about of	named entity 'aim' named entity 'thrombotic complications' named entity 'Sixteen' named entity 'D-dimer' named entity 'frequency' named entity 'anticoagulation' named entity 'DIVIDED' named entity 'DID' named entity 'divided' named entity 'inpatient' named entity 'patients' named entity 'COVID-19' named entity 'patients' named entity 'Male' named entity 'mechanical ventilation' named entity 'high' named entity 'patients' named entity 'impacted' named entity 'Patients' named entity 'started' named entity 'complications' named entity 'compared' named entity 'D-dimer' named entity 'mechanical ventilation' named entity 'anticoagulation' named entity 'anticoagulation' named entity 'COVID' named entity 'Thrombotic complications' named entity 'pneumonia' named entity 'COVID' named entity 'anticoagulation' named entity 'D-dimer' named entity 'D-dimer' named entity 'intubated' named entity 'COVID-19' named entity 'anticoagulation' named entity 'mechanical ventilation' named entity 'prophylactic' named entity 'anticoagulation' named entity 'SARS-CoV-2' named entity 'D-dimer' named entity 'transfusion' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'respiratory infection' named entity 'anticoagulation' named entity 'thrombotic complications' named entity 'anticoagulation' named entity 'clinically significant' named entity 'SARS CoV' named entity 'mechanical ventilation' named entity 'anticoagulation' named entity 'D-dimer' named entity 'anticoagulation' named entity 'D-dimer' named entity 'autopsy' named entity 'anticoagulation' named entity 'COVID' named entity 'low molecular weight heparin' named entity 'univariate analysis' named entity 'COVID' named entity 'anticoagulation' named entity 'D-dimer' named entity 'New York City' named entity 'Fisher's exact test' named entity 'anticoagulation' named entity 'New York City' named entity 'pneumonia' named entity 'mechanical ventilation' named entity 'respiratory support' named entity 'anticoagulation'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software